These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3367386)

  • 1. Decreased plasma beta-carotene levels in women with uterine cervical dysplasias and cancer.
    Palan PR; Romney SL; Mikhail M; Basu J; Vermund SH
    J Natl Cancer Inst; 1988 May; 80(6):454-5. PubMed ID: 3367386
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma levels of antioxidant beta-carotene and alpha-tocopherol in uterine cervix dysplasias and cancer.
    Palan PR; Mikhail MS; Basu J; Romney SL
    Nutr Cancer; 1991; 15(1):13-20. PubMed ID: 2017395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma ascorbic acid and beta-carotene levels in women evaluated for HPV infection, smoking, and cervix dysplasia.
    Basu J; Palan PR; Vermund SH; Goldberg GL; Burk RD; Romney SL
    Cancer Detect Prev; 1991; 15(3):165-70. PubMed ID: 1647869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum carotenoids and risk of cervical intraepithelial neoplasia in Southwestern American Indian women.
    Schiff MA; Patterson RE; Baumgartner RN; Masuk M; van Asselt-King L; Wheeler CM; Becker TM
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1219-22. PubMed ID: 11700272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma reduced and total ascorbic acid in human uterine cervix dysplasias and cancer.
    Romney SL; Basu J; Vermund S; Palan PR; Duttagupta C
    Ann N Y Acad Sci; 1987; 498():132-43. PubMed ID: 3475995
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum carotenoids and vitamins and risk of cervical dysplasia from a case-control study in Japan.
    Nagata C; Shimizu H; Yoshikawa H; Noda K; Nozawa S; Yajima A; Sekiya S; Sugimori H; Hirai Y; Kanazawa K; Sugase M; Kawana T
    Br J Cancer; 1999 Dec; 81(7):1234-7. PubMed ID: 10584887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma retinol-binding protein in human uterine cervical dysplasias and cancer.
    Palan PR; Basu J; Romney SL
    Gynecol Obstet Invest; 1989; 28(1):38-40. PubMed ID: 2777132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of micronutrients during a nine-month clinical trial of beta-carotene in women with precursor cervical cancer lesions.
    Palan PR; Chang CJ; Mikhail MS; Ho GY; Basu J; Romney SL
    Nutr Cancer; 1998; 30(1):46-52. PubMed ID: 9507512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-carotene levels in exfoliated cervicovaginal epithelial cells in cervical intraepithelial neoplasia and cervical cancer.
    Palan PR; Mikhail MS; Basu J; Romney SL
    Am J Obstet Gynecol; 1992 Dec; 167(6):1899-903. PubMed ID: 1471714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum micronutrients and the subsequent risk of cervical cancer in a population-based nested case-control study.
    Batieha AM; Armenian HK; Norkus EP; Morris JS; Spate VE; Comstock GW
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):335-9. PubMed ID: 8348056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma levels of vitamin A and its protein vectors (RBP and PA), carotene, total cholesterol and cholesterol-HDL in patients with dysplasia of the uterine cervix].
    Audisio M; Dante D; Fidanza F; Villani C; Rulli G
    Boll Soc Ital Biol Sper; 1985 Feb; 61(2):295-301. PubMed ID: 4039597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary intake and blood levels of lycopene: association with cervical dysplasia among non-Hispanic, black women.
    Kanetsky PA; Gammon MD; Mandelblatt J; Zhang ZF; Ramsey E; Dnistrian A; Norkus EP; Wright TC
    Nutr Cancer; 1998; 31(1):31-40. PubMed ID: 9682246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum alpha1 fetoprotein in gynecological malignancies.
    Restaino A; Sabatini R; Amoruso A; Ferreri R; Selvaggi L
    Eur J Gynaecol Oncol; 1981; 2(3):139-40. PubMed ID: 6182001
    [No Abstract]   [Full Text] [Related]  

  • 14. Retinoids and the prevention of cervical dysplasias.
    Romney SL; Palan PR; Duttagupta C; Wassertheil-Smoller S; Wylie J; Miller G; Slagle NS; Lucido D
    Am J Obstet Gynecol; 1981 Dec; 141(8):890-4. PubMed ID: 7198387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrients in diet and plasma and risk of in situ cervical cancer.
    Brock KE; Berry G; Mock PA; MacLennan R; Truswell AS; Brinton LA
    J Natl Cancer Inst; 1988 Jun; 80(8):580-5. PubMed ID: 3373548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum carotene, vitamin A, and vitamin C levels in breast cancer and cancer of the uterine cervix.
    Ramaswamy G; Krishnamoorthy L
    Nutr Cancer; 1996; 25(2):173-7. PubMed ID: 8710686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase-inhibitor activity in sera of patients with carcinoma of the cervix uteri.
    Benítez-Bribiesca L; Freyre-Horta R; Villalobos-Ramírez M; Pastrana L
    Arch Invest Med (Mex); 1987; 18(3):187-92. PubMed ID: 3501277
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical utility of serum tumor markers and cytokines in cervical cancer and neoplasia.
    Juan L; Tong HL; Zhang PJ; Wen XY; Gao YH; Nan JZ; Tian YP
    Clin Chem Lab Med; 2013 Aug; 51(8):e183-6. PubMed ID: 23492567
    [No Abstract]   [Full Text] [Related]  

  • 19. [Erythrocyte changes in cervix neoplasms and its preliminary stages].
    Linke A; Kruschwitz S; Gemende I; Männchen E; Fehse KH; Voss J
    Z Arztl Fortbild (Jena); 1977 Mar; 71(5):236-9. PubMed ID: 868103
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum C-reactive protein levels in patients with cervical neoplasia.
    Wong F; Arumanayagam M; Swaminathan R; Chang A
    Gynecol Obstet Invest; 1989; 27(3):166-8. PubMed ID: 2661362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.